News & Updates

Use of cardiovascular medications does not lead to poor COVID-19 clinical outcomes among high-risk patients, such as those with hypertension, according to a study.

Older patients, non‒English-speaking individuals, and ethnic/racial minorities are less likely to complete a video telemedicine encounter for ophthalmic care during the COVID-19 pandemic, a study has found.

A rehabilitation programme comprising intensive perioperative pulmonary rehabilitation (PR) and standard of care (SC) led to improved exercise capacity and tolerance in individuals with early-stage non-small-cell lung cancer (NSCLC) who are undergoing lung resection, the PUREAIR trial suggests.

Vaccines against SARS-CoV-2 has a safety profile that is similar in patients with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD) and those with noninflammatory RMD (NI-RMD), according to a study. The vaccines are well tolerated with rare reports of I-RMD flare and serious adverse events.

Patients with previously treated HER2-positive metastatic breast cancer (mBC) experienced a 31 percent reduced risk of death when treated with pyrotinib plus capecitabine than lapatinib plus capecitabine, according to updated results of the phase III PHOEBE trial from China.

Women of reproductive age who regularly use hormonal contraceptives (HCs) are at increased risk of glaucoma, suggests a recent study.